Douglas Richard is a director of MaxCyte Inc.
Person profile
Address
Cambridge, Massachusetts
Employees
Incorporated
Fiscal year end
Industry (SIC)
SEC CIK
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jun 23 | MXCT MaxCyte | Stock Option Common Stock | Grant | Acquire A | No | No | 4.57 | 50,000 | 228.50 k | 50,000 |
12 Jun 23 | NVAX Novavax | RSU Common Stock | Grant | Acquire A | No | No | 0 | 6,670 | 0.00 | 6,670 |
12 Jun 23 | NVAX Novavax | Stock Option Common Stock | Grant | Acquire A | No | No | 7.78 | 7,710 | 59.98 k | 7,710 |
10 Jun 23 | NVAX Novavax | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,100 | 0.00 | 37,250 |
10 Jun 23 | NVAX Novavax | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,100 | 0.00 | 0 |
29 Mar 23 | MXCT MaxCyte | Common Stock | Buy | Acquire P | No | No | 4.3185 | 80,000 | 345.48 k | 100,000 |